Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

NCT00235443 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00235443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy
Lead sponsor
UCB Pharma
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2004
Completion date
July 31, 2008
Enrollment
451 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy